Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 290.7452
Recommendation STRONG BUY
P/E 44.99
ROE 100.00 %
Capitalization 293,410,164,996 $
Dividend Yield 2.09 %
P/S 9.76
AII Position 14
P/E Position 570
ROE Position 28
Capitalization Position 16
Dividend Yield Position 308
Sales 23,923,000,000 £
10-Year Average Earnings 5,192,400,000 £
Shares Outstanding 4,888,000,000
Equity 5,114,000,000 £
Dividend per Share 1 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £
2007 12 5,310,000,000.00 £
2006 12 5,498,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £
2007 12 9,910,000,000.00 £
2006 12 9,648,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000
2007 12 5,567,000,000
2006 12 5,700,000,000

 












Bloomberg News for GLAXOSMITHKLINE:

Sep 26, 2017
Axovant Interpidine Trial Failure: Living Down To Expectations
Axovant bought intepirdine from its original developer GlaxoSmithKline PLC for a meager $5 million up front. GSK had shelved the drug after it failed multiple clinical trials. In those failures...
Sep 4, 2017
Novartis Calls for the Doctor
scientist back at the helm of the Swiss drugmaker just months after rival GlaxoSmithkline Plc went the other way and installed a marketing executive to the top job. Narasimhan inherits a mixed...
Jul 27, 2017
Eli Lilly, GlaxoSmithKline Earnings: R&D Overhauls? Good Luck
succeed, divest a bunch of assets and try again.This week, Eli Lilly & Co. and GlaxoSmithKline PLC both announced earnings that exceeded analyst estimates. But their share prices didn't benefit, as...
Jul 6, 2017
Here Are the CEOs Who Got Tickets to a Country Mansion to Talk Brexit
Carolyn McCall, eastJet23. Martin McTague, Federation of Small Businesses24. Helena Morrissey, L&G Investments25. Nick Owen, Deloitte26. Gavin Patterson, BT Group27. John Pettigrew, National Grid28...


Google News for GLAXOSMITHKLINE:

Baldwin Journal (blog) - 8 hours ago
Indicator Spotter: Watching the Numbers on Shares of ...
Tracking recent technical action on shares of Glaxosmithkline Plc (GSK.L), we have identified that Span A is now above Span B. Following ...
MTNV - 12 hours ago
Glaxosmithkline Plc (GSK.L) Share Activity Climbing in Session
Shares of Glaxosmithkline Plc (GSK.L) is moving on volatility today 0.16% or 2.50 from the open. The LSE listed company saw a recent bid of ...
Financial Newsweek - 14 hours ago
Glaxosmithkline Plc (GSK.L)'s Technicals Placed in the Limelight
Shares of Glaxosmithkline Plc (GSK.L) are moving on volatility today 0.16% or 2.50 from the open. The LSE listed company saw a recent bid of ...
Financial Newsweek - 18 hours ago
Glaxosmithkline Plc (GSK.L) Near-Term Moving Average Signal ...
Shares of Glaxosmithkline Plc (GSK.L) are heading in a near-term positive direction as the most recent close of the company has stayed above ...
Investomania (blog) - 21 hours ago
4 stocks set to beat the FTSE 100? Prudential plc, GlaxoSmithKline ...
Do these 4 share prices have FTSE 100-outperforming potential? Prudential plc (LON:PRU) (PRU.L), GlaxoSmithKline plc (LON:GSK) (GSK.L) ...
Danville Daily (blog) - 1 day ago
Technical Update on Glaxosmithkline Plc (GSK.L) Shares
Active traders may be zooming in on certain technical indicators for stock assessment. Currently, Glaxosmithkline Plc (GSK.L) has a 14-day ...
euronews - 3 days ago
GlaxoSmithKline's shingles vaccine gets approval in Canada
(Reuters) – Canadian health regulators have approved GlaxoSmithKline's <GSK.L> key shingles vaccine, the company said on Friday. Shingrix ...
Reuters UK - 2 Oct 2017
US judge dismisses ex-sleuths' lawsuit against GlaxoSmithKline
(Reuters) - A U.S. judge has dismissed a lawsuit by two former corporate investigators who accused GlaxoSmithKline Plc (GSK.L) (GSK) of ...
Reuters.com - 9 Oct 2017
UK PM May tells business chiefs: two-year Brexit transition is ...
May met business chiefs from GlaxoSmithKline (GSK.L), Vodafone (VOD.L) and HSBC (HSBA.L) and other major companies on Monday to ...
AppsforPCdaily
FDA Okays GSK's Three-in-one Drug Inhaler For COPD
(RTTNews.com) - GlaxoSmithKline plc (GSK.L, GSK) and Innoviva Inc. (INVA) said that the US Food and Drug Administration has approved ...


Back